{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:25:22Z","timestamp":1771478722027,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>(1) Background: Atrial fibrillation (AF) is the most common arrhythmia causing an increased risk of mortality and morbidity. It is classified into paroxysmal and non-paroxysmal AF depending on the duration and frequency of the episodes. (2) Aims: Our goal was to investigate and compare the clinical profiles, risk of co-morbidities, the use of oral anticoagulation, and outcomes of patients with paroxysmal and non-paroxysmal AF in inpatient and outpatient settings. (3) Methods: Data were extracted from 28 different hospitals and centers in Jordan with a total of 2160 patients enrolled in the study using an observational non-interventional study model. The clinical features and the use of oral anticoagulants were compared in patients with paroxysmal and non-paroxysmal AF. (4) Results: Paroxysmal AF was documented in 35.6% (769) of the patients and non-paroxysmal types in 63.9% (1380); in addition, the type of AF was unknown in 11 (0.5%) patients. Our results showed that non-paroxysmal AF patients tend to be older with more co-morbidities and higher CHA2DS2-VASC and HAS-BLED scores. They also have higher rates of hypertension and diabetes. Anticoagulant, antiarrhythmic, and diuretic agents, overall, were used more in non-paroxysmal AF than paroxysmal AF. Hospital admissions were also more frequent in non-paroxysmal AF due to various factors, some of which are heart failure, bleeding risk, and COPD. (5) Conclusions: Non-paroxysmal AF is more common among Jordanian AF patients. The prevalence of comorbidities and the use of different types of therapies, especially anticoagulants, were higher in these patients.<\/jats:p>","DOI":"10.3390\/ijerph19106173","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T12:25:57Z","timestamp":1652963157000},"page":"6173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study"],"prefix":"10.3390","volume":"19","author":[{"given":"Hanna","family":"Al-Makhamreh","sequence":"first","affiliation":[{"name":"Department of Cardiology, School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5541-8362","authenticated-orcid":false,"given":"Nasr","family":"Alrabadi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Haikal","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-3047","authenticated-orcid":false,"given":"Mohammad","family":"Krishan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Al-Badaineh","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6215-8423","authenticated-orcid":false,"given":"Osama","family":"Odeh","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6709-9127","authenticated-orcid":false,"given":"Tawfiq","family":"Barqawi","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-5713","authenticated-orcid":false,"given":"Mohammed","family":"Nawaiseh","sequence":"additional","affiliation":[{"name":"King Hussein Medical Center, Royal Medical Services, Amman 11855, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala","family":"Shaban","sequence":"additional","affiliation":[{"name":"King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-3951","authenticated-orcid":false,"given":"Basil","family":"Abdin","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11972, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama","family":"Khamies","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Hammoudeh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istishari Hospital, Amman 11184, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: Relationships among clinical features, epidemiology, and mechanisms: Relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40266-013-0094-8","article-title":"Atrial fibrillation in the elderly","volume":"30","author":"Nantsupawat","year":"2013","journal-title":"Drugs Aging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ. Res."},{"key":"ref_5","first-page":"179","article-title":"Predisposing factors for atrial fibrillation in the elderly","volume":"14","author":"Wasmer","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"ref_7","first-page":"109","article-title":"Management of atrial fibrillation","volume":"3","author":"Kakar","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","article-title":"Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline","volume":"113","author":"Sacco","year":"2006","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/heartjnl-2016-310927","article-title":"The treatment of paroxysmal atrial fibrillation in UK primary care","volume":"103","author":"Isaew","year":"2017","journal-title":"Heart"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/qjmed\/94.12.665","article-title":"Paroxysmal atrial fibrillation","volume":"94","author":"Lip","year":"2001","journal-title":"QJM"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1253\/circj.68.568","article-title":"Progressive Nature of Paroxysmal Atrial Fibrillation","volume":"68","author":"Kato","year":"2004","journal-title":"Circ. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: Insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_13","first-page":"648","article-title":"\u201cReal-world\u201d management and outcomes of patients with paroxysmal vs. non-pmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation aroxys (EORP-AF) General Pilot Registry","volume":"18","author":"Boriani","year":"2016","journal-title":"EP Eur."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: Results from the ARISTOTLE trial","volume":"34","author":"Thomas","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists","volume":"99","author":"Maarek","year":"1999","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.STR.17.4.622","article-title":"Embolic complications in paroxysmal atrial fibrillation","volume":"17","author":"Petersen","year":"1986","journal-title":"Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: Results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e16560","DOI":"10.1097\/MD.0000000000016560","article-title":"Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)","volume":"98","author":"Leddy","year":"2019","journal-title":"Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00392-011-0320-5","article-title":"Management of atrial fibrillation by primary care physicians in Germany: Baseline results of the ATRIUM registry","volume":"100","author":"Meinertz","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2017.06.038","article-title":"Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablation","volume":"244","author":"Okawa","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kim, Y.G., Shim, J., Boo, K.Y., Kim, D.Y., Oh, S.-K., Lee, K.-N., Choi, J.-I., and Kim, Y.-H. (2019). Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214743"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2020.06.046","article-title":"Differences in thromboembolic complications between paroxysmal and persistent atrial fibrillation patients following electrical cardioversion (from the ENSURE-AF study)","volume":"131","author":"Goette","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: Analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00129784-200202010-00005","article-title":"Use of beta-blockers in atrial fibrillation","volume":"2","author":"Bosch","year":"2002","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: Baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2019.07.048","article-title":"Age-dependent prognostic impact of paroxysmal versus sustained atrial fibrillation on the incidence of cardiac death and heart failure hospitalization (the Fushimi AF Registry)","volume":"124","author":"An","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.amjcard.2013.12.024","article-title":"Prognosis in patients hospitalized with permanent and nonpermanent atrial fibriltion in heart failure","volume":"113","author":"Taillandier","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am. J. Med."},{"key":"ref_31","first-page":"1922","article-title":"Symptomatic atrial fibrillation and risk of cardiovascular events: Data from the Euro Heart Survey","volume":"19","author":"Guerra","year":"2017","journal-title":"EP Eur."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1111\/jce.14838","article-title":"Women and atrial fibrillation","volume":"32","author":"Volgman","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/10\/6173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:38Z","timestamp":1760138078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/10\/6173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijerph19106173"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19106173","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}